Treat and Prevent
Lung cancer research
More than 90,000 men and 79,000 women are diagnosed each year with cancer of the lungs and bronchi (the air tubes leading to the lungs). Among men, the incidence of lung cancer has been declining, but it continues to increase among women. The number of lung cancer deaths among women surpasses those from breast cancer.
Your gift will support current research into new agents to treat lung cancer and prevent its recurrence. Memorial Sloan-Kettering researchers are evaluating new drugs for lung cancer, including getifinib (Iressa). First tested at MSKCC, getitinib is one of a new class of drugs known as signal transduction inhibitors, which work by blocking the signal that make cancer cells grow and spread.